The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...

Information on the disease and treatments, assistance with insurance, and transportation are among the types of support ...

In addition to being diagnosed more frequently in older patients, pulmonary arterial hypertension (PAH) is more frequently ...

Rachel Dalthorp, MD, discusses how zuranolone (Zurzuvae) can improve postpartum depression when compared with previous ...

This interview accompanies the third podcast in our National Recovery Month series with Kim MacDonald-Wilson, ScD, CPRP, ...

Anant Madabhushi, PhD, executive director for the Emory Empathetic AI for Health Institute, discusses the potential of ...

More than 25 million people lost their Medicaid coverage during the unwinding process conducted by all states after the ...

Coverage from the Institute for Value-Based Medicine session at Ohio State University. This article will appear in the ...

Findings from a new study reveal significant racial differences in skin biopsy frequency for psoriasis diagnosis, indicating ...

Joseph Alvarnas, MD, of City of Hope, recaps yesterday's Institute for Value-Based Medicine® (IVBM) event on value-based oncology care, emphasizing patient-centered approaches and how attendees can ...

The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...

The US health care system is underperforming despite high spending, and reform is needed in areas like insurance coverage, ...